Viewing Study NCT05421468


Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2026-02-12 @ 3:37 PM
Study NCT ID: NCT05421468
Status: UNKNOWN
Last Update Posted: 2022-06-16
First Post: 2022-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Timing of Thyroxine Dose In Ramadan
Sponsor: King Abdullah International Medical Research Center
Organization:

Study Overview

Official Title: Timing of Thyroxine Dose In Ramadan; a Randomized Control Trial
Status: UNKNOWN
Status Verified Date: 2022-06
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A Randomized trial comparing two different timing of taking thyroxine in patients with Hypothyroidism during fasting the month of Ramadan.
Detailed Description: To date there is debate regarding the best timing of L-thyroxine administration during Ramadan as sufficient evidence is lacking. This study aims to compare two-time points of levothyroxine intake during Ramadan focusing on change in TSH, satisfaction and compliance.

A prospective, randomized, open label, multicenter Study. The first group will be will be instructed to take their L-thyroxin dose as per current guidlines at breaking of fast time (sunset) with sip of water then wait 30-60 minutes to consume Iftar meal. The second group (pre-Fajer prayer), patients are going to be instructed to take L-thyroxin dose immediately before start of fast, i.e. Alfajer (dawn) regardless of Suhoor time. The values of Thyroid stimulating hormone (TSH) will be measured two weeks before Ramadan, and 2-4 weeks after Ramadan for comparison.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: